Telomeres and Telomerase: From Discovery to Clinical Trials

Research output: Contribution to journalComment/debatepeer-review

42 Scopus citations


Telomeres are the ends of linear chromosomes. They cannot be fully replicated by standard polymerases and are maintained by the ribonucleoprotein telomerase. Telomeres and telomerase stand at a junction of critical processes underlying chromosome integrity, cancer, and aging, and their importance was recognized by the 2009 Nobel Prize in Physiology or Medicine to Elizabeth Blackburn, Jack Szostak, and Carol Greider. Where will the field go now? What are the prospects for antitelomerase agents as drugs? Nearly 30 years after Szostak and Blackburn's pioneering manuscript on telomere ends, the challenges of discovery remain.

Original languageEnglish (US)
Pages (from-to)1219-1223
Number of pages5
JournalChemistry and Biology
Issue number12
StatePublished - Dec 24 2009



ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry


Dive into the research topics of 'Telomeres and Telomerase: From Discovery to Clinical Trials'. Together they form a unique fingerprint.

Cite this